academic article

• The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging..  AIDS research and human retroviruses.  36:973-981. 2020
• Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy..  Journal of acquired immune deficiency syndromes (1999).  80:89-93. 2019
• Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy..  AIDS (London, England).  25:2123-31. 2011
• Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach..  PloS one.  6:-. 2011
• Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals..  AIDS (London, England).  24:2535-9. 2010
• Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen..  The Journal of infectious diseases.  195:387-91. 2006
• Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection..  The Journal of infectious diseases.  192:1537-44. 2005
• Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1..  The Journal of infectious diseases.  189:312-21. 2004
• Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy..  AIDS (London, England).  17:1907-15. 2003